Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on One pot Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a green, one-pot synthesis for 4-aryl-4,5-dihydrofurans using K2CO3. Eliminate heavy metals and reduce costs for reliable pharmaceutical intermediate supply.
Patent CN106146418B reveals a metal-free one-pot route for high-purity NH-1,2,3-triazole. This method offers substantial cost reduction in API intermediate manufacturing and supply chain reliability.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and scalable pharma intermediate production.
Patent CN105111217B reveals efficient copper-catalyzed one-pot synthesis. Delivers high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.
Patent CN109265385B discloses a low-cost, high-yield synthesis of chiral diphenyl prolinol using sulfuric acid catalysis, offering significant supply chain advantages.
Patent CN112480015B reveals a Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable production capabilities.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN115960142A discloses a one-pot synthesis of osmium heterocycles enabling high-yield hydrosilylation under air, offering cost-effective solutions for fine chemical manufacturing.
Patent CN110183378A details a copper-catalyzed route for high-purity pharmaceutical intermediates. This method offers significant cost reduction and supply chain reliability for global buyers.
Patent CN117229206B enables efficient 2-quinolinone synthesis. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing globally.
Patent CN110183378A reveals high-yield catalytic route for nicotinamide derivatives ensuring supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel one-pot synthesis for 9H-pyrimido[4,5-b]indoles using copper catalysis. Reduces steps and cost for pharmaceutical intermediates.
Novel one-pot synthesis of 2-alkyl quinolines using montmorillonite and iodine. High yield, low toxicity, scalable pharmaceutical intermediate manufacturing.
Patent CN108864189A reveals a novel one-pot synthesis for sulfinamide chiral ligands, enabling cost-effective production of high-purity pharmaceutical intermediates via asymmetric Heck reactions.
Novel one-pot method for etoposide intermediate. Reduces cost, improves safety, ensures high purity for pharmaceutical supply chains.
Patent CN103333144A reveals a high-yield one-pot synthesis for 2-sulfenyl-3-halo benzofurans, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Patent CN110590760B reveals a novel one-pot synthesis for anticancer intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN112480015B details a novel one-pot Pd-catalyzed method using nitro compounds, offering cost-effective and scalable production of high-purity quinazolinone derivatives.
Patent CN110092751B reveals a green one-pot method for 2-alkyl quinolines using montmorillonite and iodine, offering significant cost reduction and supply chain stability.